The Benefit-Risk Assessment of New Treatments: The Health Technology Assessment (HTA) Process
September 22, 2022
September 22, 2022 | 5:00-6:00 PM CEST | 11:00 AM – 12:00 PM EDT ABSTRACT The increasing cost of new…
Resources
Resources
Free Resources Library related to clinical trial innovation : Discover our recorded webinars, service flyers, experience, white papers and more related to clinical development.
AN INNOVATIVE STATISTICAL METHODOLOGY
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
Conversation between a Sponsor and a Statistician about Phase II/III trials in oncology
June 23, 2022
Learn on the features, advantages and disadvantages of adaptive designs and group-sequential designs and their regulatory aspects of Phase II/III trials…
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
March 24, 2022 — March 24, 2022
This webinar presented the results of a new study that further demonstrated that risk-based monitoring is an efficient tool to…
Integrating Technology and Expertise
Phase I/II study in cancer patients showcases eClinical effectiveness. An Article written by IDDI Published in Applied Clinical Trials, February…
Good Morning Meeting | Generalized Pairwise Comparisons (GPC): An innovative statistical method to design and analyze clinical trials
In collaboration with MVA, IDDI team is pleased to invite you to a Good Morning Meeting COPENHAGEN, DENMARK | APRIL…
Assessing treatment efficacy in early-phase oncology trials
February 3, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! ABSTRACT: One of the major recent…
Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
December 2, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…
IDDI 30 YEAR ANNIVERSARY
2021 marks IDDI’s 30 year anniversary We are truly grateful to the 350+ pharmaceutical and biotech companies, as well as…
ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
October 26, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…